Cargando…
Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study
BACKGROUND AND AIMS: Stool DNA testing is an emerging and attractive option for colorectal cancer (CRC) screening. We previously evaluated the feasibility of a stool DNA (sDNA) test of methylated SDC2 for CRC detection. The aim of this study was to assess its performance in a multicenter clinical tr...
Autores principales: | Wang, Jianping, Liu, Side, Wang, Hui, Zheng, Lei, Zhou, Changchun, Li, Guoxin, Huang, Rongkang, Wang, Huaiming, Li, Chujun, Fan, Xinjuan, Fu, Xinhui, Wang, Xinying, Guo, Hongliang, Guan, Jie, Sun, Yanlai, Song, Xilin, Li, Zengjun, Mu, Dianbin, Sun, Jujie, Liu, Xianglin, Qi, Yan, Niu, Feng, Chen, Chunhua, Wu, Xiaolin, Wang, Xianshu, Song, Xianrang, Zou, Hongzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602331/ https://www.ncbi.nlm.nih.gov/pubmed/33126908 http://dx.doi.org/10.1186/s13148-020-00954-x |
Ejemplares similares
-
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
por: Zhang, Weisong, et al.
Publicado: (2021) -
Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
por: Oh, Tae Jeong, et al.
Publicado: (2017) -
Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021) -
Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
por: Zhao, Guodong, et al.
Publicado: (2020) -
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
por: Han, Yoon Dae, et al.
Publicado: (2019)